The coronavirus outbreak could make it quicker and easier to trial drugs.

Ledford, Heidi

Ledford, Heidi.

Nature ; 582(7811): 172, 2020 06.

Article in English | MEDLINE | ID: covidwho-1442737

Subject(s)

Betacoronavirus/drug effects; Clinical Trials as Topic/methods; Clinical Trials as Topic/organization & administration; Coronavirus Infections/drug therapy; Drug Industry/methods; Hydroxychloroquine/pharmacology; Hydroxychloroquine/therapeutic use; Pneumonia, Viral/drug therapy; COVID-19; Coronavirus Infections/virology; Drug Development/methods; Drug Development/organization & administration; Drug Development/trends; Drug Industry/organization & administration; Humans; Pandemics; Patient Selection; Pneumonia, Viral/virology; SARS-CoV-2; Time Factors; United States; United States Food and Drug Administration/legislation & jurisprudence

Keywords

Business; Drug discovery; Industry; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Clinical Trials as Topic / Coronavirus Infections / Drug Industry / Betacoronavirus / Hydroxychloroquine Type of study: Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: North America Language: English Journal: Nature Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google